Wednesday, July 8, 2026

biotech · Relapsed or Refractory B-cell Malignancies · Solid Tumor · RXRX

RECURSION PHARMACEUTICALS

News and analysis for RECURSION PHARMACEUTICALS on NovaPharmaNews — regulatory, clinical, and market coverage.

Staten Island, USA HQ
11 Employees
Public company Type
RXRX · NYSE Ticker
Company details
Status
Public
HQ
Staten Island, USA
Employees
11
Programs
9
Drugs
2
Patents
4
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning RECURSION PHARMACEUTICALS — regulatory, clinical, and market coverage.

News and analysis for RECURSION PHARMACEUTICALS on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning RECURSION PHARMACEUTICALS yet.

Back to company overview →